234 related articles for article (PubMed ID: 20187302)
1. Developmental tumourigenesis: NCAM as a putative marker for the malignant renal stem/progenitor cell population.
Pode-Shakked N; Metsuyanim S; Rom-Gross E; Mor Y; Fridman E; Goldstein I; Amariglio N; Rechavi G; Keshet G; Dekel B
J Cell Mol Med; 2009 Aug; 13(8B):1792-1808. PubMed ID: 20187302
[TBL] [Abstract][Full Text] [Related]
2. Expression of stem cell markers in the human fetal kidney.
Metsuyanim S; Harari-Steinberg O; Buzhor E; Omer D; Pode-Shakked N; Ben-Hur H; Halperin R; Schneider D; Dekel B
PLoS One; 2009 Aug; 4(8):e6709. PubMed ID: 19696931
[TBL] [Abstract][Full Text] [Related]
3. Resistance or sensitivity of Wilms' tumor to anti-FZD7 antibody highlights the Wnt pathway as a possible therapeutic target.
Pode-Shakked N; Harari-Steinberg O; Haberman-Ziv Y; Rom-Gross E; Bahar S; Omer D; Metsuyanim S; Buzhor E; Jacob-Hirsch J; Goldstein RS; Mark-Danieli M; Dekel B
Oncogene; 2011 Apr; 30(14):1664-80. PubMed ID: 21472018
[TBL] [Abstract][Full Text] [Related]
4. Blastemal NCAM
Raved D; Tokatly-Latzer I; Anafi L; Harari-Steinberg O; Barshack I; Dekel B; Pode-Shakked N
Pathol Res Pract; 2019 Aug; 215(8):152491. PubMed ID: 31202518
[TBL] [Abstract][Full Text] [Related]
5. The isolation and characterization of renal cancer initiating cells from human Wilms' tumour xenografts unveils new therapeutic targets.
Pode-Shakked N; Shukrun R; Mark-Danieli M; Tsvetkov P; Bahar S; Pri-Chen S; Goldstein RS; Rom-Gross E; Mor Y; Fridman E; Meir K; Simon A; Magister M; Kaminski N; Goldmacher VS; Harari-Steinberg O; Dekel B
EMBO Mol Med; 2013 Jan; 5(1):18-37. PubMed ID: 23239665
[TBL] [Abstract][Full Text] [Related]
6. Molecular and epidemiologic characterization of Wilms tumor from Baghdad, Iraq.
Phelps HM; Al-Jadiry MF; Corbitt NM; Pierce JM; Li B; Wei Q; Flores RR; Correa H; Uccini S; Frangoul H; Alsaadawi AR; Al-Badri SAF; Al-Darraji AF; Al-Saeed RM; Al-Hadad SA; Lovvorn Iii HN
World J Pediatr; 2018 Dec; 14(6):585-593. PubMed ID: 30155617
[TBL] [Abstract][Full Text] [Related]
7. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
8. Wilms tumor--a renal stem cell malignancy?
Pode-Shakked N; Dekel B
Pediatr Nephrol; 2011 Sep; 26(9):1535-43. PubMed ID: 21499773
[TBL] [Abstract][Full Text] [Related]
9. Wilms' tumor blastemal stem cells dedifferentiate to propagate the tumor bulk.
Shukrun R; Pode-Shakked N; Pleniceanu O; Omer D; Vax E; Peer E; Pri-Chen S; Jacob J; Hu Q; Harari-Steinberg O; Huff V; Dekel B
Stem Cell Reports; 2014 Jul; 3(1):24-33. PubMed ID: 25068119
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of neural cell adhesion molecule in Wilms tumors, nephrogenic rests, and fetal and postnatal renal cortices.
Kapur P; Rakheja D
Pediatr Dev Pathol; 2011; 14(1):16-9. PubMed ID: 20524836
[TBL] [Abstract][Full Text] [Related]
11. SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor.
Murphy AJ; Pierce J; de Caestecker C; Taylor C; Anderson JR; Perantoni AO; de Caestecker MP; Lovvorn HN
J Pediatr Surg; 2012 Jun; 47(6):1239-49. PubMed ID: 22703800
[TBL] [Abstract][Full Text] [Related]
12. Multidimensional Transcriptomics Unveils RNF34 as a Prognostic Biomarker and Potential Indicator of Chemotherapy Sensitivity in Wilms' Tumour.
Zheng J; Liu F; Tuo J; Chen S; Su J; Ou X; Ding M; Chen H; Shi B; Li Y; Chen X; Wang C; Su C
Mol Biotechnol; 2024 May; 66(5):1132-1143. PubMed ID: 38195816
[TBL] [Abstract][Full Text] [Related]
13. Expression of stem cell markers, CD133 and CD44, in pediatric solid tumors: a study using tissue microarray.
Mehrazma M; Madjd Z; Kalantari E; Panahi M; Hendi A; Shariftabrizi A
Fetal Pediatr Pathol; 2013 Jun; 32(3):192-204. PubMed ID: 22830353
[TBL] [Abstract][Full Text] [Related]
14. Dissecting Stages of Human Kidney Development and Tumorigenesis with Surface Markers Affords Simple Prospective Purification of Nephron Stem Cells.
Pode-Shakked N; Pleniceanu O; Gershon R; Shukrun R; Kanter I; Bucris E; Pode-Shakked B; Tam G; Tam H; Caspi R; Pri-Chen S; Vax E; Katz G; Omer D; Harari-Steinberg O; Kalisky T; Dekel B
Sci Rep; 2016 Mar; 6():23562. PubMed ID: 27020553
[TBL] [Abstract][Full Text] [Related]
15. Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney.
Dekel B; Metsuyanim S; Schmidt-Ott KM; Fridman E; Jacob-Hirsch J; Simon A; Pinthus J; Mor Y; Barasch J; Amariglio N; Reisner Y; Kaminski N; Rechavi G
Cancer Res; 2006 Jun; 66(12):6040-9. PubMed ID: 16778176
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of CD44 and CD24 markers discriminates the epitheliod from the fibroblastoid subset in a sarcomatoid renal carcinoma cell line: evidence suggesting the existence of cancer stem cells in both subsets as studied with sorted cells.
Hsieh CH; Hsiung SC; Yeh CT; Yen CF; Chou YW; Lei WY; Pang ST; Chuang CK; Liao SK
Oncotarget; 2017 Feb; 8(9):15593-15609. PubMed ID: 28121626
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of favorable histology Wilms tumors and its correlation with clinical features.
Takahashi M; Yang XJ; Lavery TT; Furge KA; Williams BO; Tretiakova M; Montag A; Vogelzang NJ; Re GG; Garvin AJ; Söderhäll S; Kagawa S; Hazel-Martin D; Nordenskjold A; Teh BT
Cancer Res; 2002 Nov; 62(22):6598-605. PubMed ID: 12438255
[TBL] [Abstract][Full Text] [Related]
18. NCAM and FGFR1 coexpression and colocalization in renal tumors.
Ćirović S; Vještica J; Mueller CA; Tatić S; Vasiljević J; Milenković S; Mueller GA; Marković-Lipkovski J
Int J Clin Exp Pathol; 2014; 7(4):1402-14. PubMed ID: 24817936
[TBL] [Abstract][Full Text] [Related]
19. CITED1 confers stemness to Wilms tumor and enhances tumorigenic responses when enriched in the nucleus.
Murphy AJ; Pierce J; de Caestecker C; Ayers GD; Zhao A; Krebs JR; Saito-Diaz VK; Lee E; Perantoni AO; de Caestecker MP; Lovvorn HN
Oncotarget; 2014 Jan; 5(2):386-402. PubMed ID: 24481423
[TBL] [Abstract][Full Text] [Related]
20. Expression of TCF3 in Wilms' tumor and its regulatory role in kidney tumor cell viability, migration and apoptosis
Zhou N; Yan B; Ma J; Jiang H; Li L; Tang H; Ji F; Yao Z
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
